Skip to search formSkip to main contentSkip to account menu

Copper Cu 64 Plerixafor

Known as: 64-Cu-plerixafor 
A radioconjugate labeled with the positron-emitting radioisotope, copper Cu 64, and also composed of plerixafor, a bicyclam and hematopoietic stem… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Notch signaling is a well-known key player in the communication between adjacent cells during organ development, when it controls… 
2016
2016
PurposeChemokine receptor 4 (CXCR4) is overexpressed in many cancers and a potential drug target. We have recently developed the… 
2015
2015
In the present study, a series of copolymers (PAMD-Ch) was synthesized by grafting polymeric Plerixafor/AMD3100 (PAMD) with… 
2014
2014
While extensive data demonstrated that plerixafor improves stem cell harvest in difficult‐to‐mobilize patients, economic concerns… 
2014
2014
Plerixafor ‘on demand’: results of a strategy based on peripheral blood CD34+ cells in lymphoma patients at first or subsequent… 
2013
2013
In Europe, the combination of plerixafor + granulocyte colony-stimulating factor is approved for the mobilization of… 
2013
2013
The efficacy and safety of plerixafor + G‐CSF in enhancing hematopoietic stem cell mobilization and collection has been… 
Highly Cited
2012
Highly Cited
2012
Compelling evidence has emerged in recent years indicating that stromal cells play a critical role in disease progression. CXCR4… 
2009
2009
Abstract 33 Background: Circulating levels of peripheral blood (PB) CD34+ cells/μl are a strong predictor of hematopoietic stem…